Use of US Public Health Travel Restrictions during COVID-19 Outbreak on Diamond Princess Ship, Japan, February-April 2020.

COVID-19 Diamond Princess Japan SARS-CoV-2 United States cluster coronavirus disease cruise ship epidemic pandemic public health respiratory infections severe acute respiratory syndrome coronavirus 2 travel restrictions viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 30 1 2021
medline: 6 3 2021
entrez: 29 1 2021
Statut: ppublish

Résumé

Public health travel restrictions (PHTR) are crucial measures during communicable disease outbreaks to prevent transmission during commercial airline travel and mitigate cross-border importation and spread. We evaluated PHTR implementation for US citizens on the Diamond Princess during its coronavirus disease (COVID-19) outbreak in Japan in February 2020 to explore how PHTR reduced importation of COVID-19 to the United States during the early phase of disease containment. Using PHTR required substantial collaboration among the US Centers for Disease Control and Prevention, other US government agencies, the cruise line, and public health authorities in Japan. Original US PHTR removal criteria were modified to reflect international testing protocols and enable removal of PHTR for persons who recovered from illness. The impact of PHTR on epidemic trajectory depends on the risk for transmission during travel and geographic spread of disease. Lessons learned from the Diamond Princess outbreak provide critical information for future PHTR use.

Identifiants

pubmed: 33513333
doi: 10.3201/eid2703.203820
pmc: PMC7920645
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

710-718

Références

Health Secur. 2018 Jan/Feb;16(1):8-13
pubmed: 29406796
Emerg Infect Dis. 2020 Jul;26(7):1470-1477
pubmed: 32255761
J Clin Med. 2020 Feb 29;9(3):
pubmed: 32121356
MMWR Morb Mortal Wkly Rep. 2020 Feb 07;69(5):140-146
pubmed: 32027631
Nat Med. 2020 Jun;26(6):861-868
pubmed: 32327757
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):312-313
pubmed: 32191689
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):347-352
pubmed: 32214086
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):465-471
pubmed: 32298250
J Travel Med. 2020 May 18;27(3):
pubmed: 32109273
Disaster Med Public Health Prep. 2020 Aug;14(4):506-513
pubmed: 32207674
MMWR Morb Mortal Wkly Rep. 2008 Sep 19;57(37):1009-12
pubmed: 18802409
Infect Dis Model. 2020 Feb 29;5:264-270
pubmed: 32190785
Travel Med Infect Dis. 2017 Jul - Aug;18:30-35
pubmed: 28648932
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415
pubmed: 32271722
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):599-602
pubmed: 32407299
MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):51-4
pubmed: 26820056
Emerg Infect Dis. 2017 Dec;23(13):
pubmed: 29155659

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH